Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

Highlights of Valoctogene Raxaparvovec

- Valoctocogene Roxaparvovec is an investigational gene therapy treatment for Hemophilia A developed by Biomarin

- FDA issued the complete response letter requesting two years of durability data from the phase 3 study

- EMA: Biomarin withdrew MMA application marketing authorization

- Biomarin is awaiting one-year of Phase 3data for EMA resubmission and two years of Phase 3 data for FDA submission

- If approved, it will become first-in-class gene therapy for the treatment of Severe Hemophilia A

For Details Visit

Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A

Comments

MCQs on Neisseria gonorrhoeae and Neisseria meningitidis: Medical microbiology

Multiple Choice Questions on Neisseria species (Gram-negative cocci) 1) A 19-year-old female college freshman, presented to the university health center with a severe headache, fever, and a stiff neck. She lived in a dormitory and was active in various social activities. She had received all her childhood vaccinations but had not received a booster for the meningococcal vaccine recommended before college entry. Clinical Presentation: On day 1, the patient experienced a sudden onset of fever (39.5°C or 103.1°F), severe headache, nausea, and vomiting. She also noticed a rash on her trunk and legs. Over the next two days, her symptoms deteriorated further, leading to photophobia and altered mental status. Concerned, her roommates brought her to the university health center. Physical Examinati...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia. Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells. c) Patients with uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above 3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose c) Insulin ...

Pentose Phosphate Pathway: Source of NADPH for Reductive Biosynthesis (Biochemistry)

Introduction to Pentose Phosphate Pathway The pentose phosphate pathway ( Hexose monophosphate pathway ) is the metabolic pathway that occurs in the cytosol and generates NADPH (nicotinamide adenine dinucleotide phosphate) which is utilized in various biosynthetic pathways. This pathway can be broadly classified into two phases i.e oxidative phase and non-oxidative phase. In the oxidative stage of the pentose phosphate pathway, the glucose-6-phosphate is converted to five carbon ribulose-5 phosphate with generation of NADPH. During the non-oxidative stage, the interconversion of pentose sugars and hexose sugars is catalyzed by isomerases and aldolases. The fate of these reversible steps depends on the anabolic and energy status of the cells. The two primary functions of the pentose phosphate pathway are ; a) Provide NADPH (a coenzyme) for biosynthetic pathways b) Provide pentose sugars for nucleotides (DNA and RNA) synthesis Two phases of Pentose phosphat...

BIOCHEMISTRY, BIOMEDICINE & PHARMACEUTICS

Search This Blog